Latest Pacific Biosciences of California (PACB)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Latest Pacific Biosciences of California (PACB) Headlines

Nasdaq stocks posting largest percentage decreases
AP - Mon Mar 10, 5:09PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:

31.8% Return Seen to Date on SmarTrend Pacific Biosciences of California Call (PACB)
Comtex SmarTrend(R) - Fri Mar 07, 4:56PM CST
SmarTrend identified an Uptrend for Pacific Biosciences of California (NASDAQACB) on December 16th, 2013 at $5.06. In approximately 3 months, Pacific Biosciences of California has returned 31.82% as of today's recent price of $6.67.

PacBio, the Post-Hype Sleeper of Genomics
Luke Timmerman, The Motley Fool - Motley Fool - Mon Mar 03, 1:22PM CST
Hype and biotech go hand in hand, but genomics takes exaggeration up  a few extra notches . When genomics companies fail, they tend to crash especially hard. Yet every now and then, a company that is monumentally hyped falls flat and then figures out...

Pacific Biosciences of California Has Returned 43.7% Since SmarTrend Recommendation (PACB)
Comtex SmarTrend(R) - Fri Feb 21, 9:38AM CST
SmarTrend identified an Uptrend for Pacific Biosciences of California (NASDAQACB) on December 16th, 2013 at $5.06. In approximately 2 months, Pacific Biosciences of California has returned 43.68% as of today's recent price of $7.27.

Pacific Biosciences (PACB) Jumps: Stock Moves 8.3% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Feb 19, 8:46AM CST
Pacific Biosciences was a big mover last session, with shares rising over 8%.

4 Biotech Stocks Under $10 to Watch
at The Street - Tue Feb 18, 1:30PM CST
Keep these under-$10 biotech stocks trading on unusual volume on your radar.

Pacific Biosciences of California Up 25.1% Since SmarTrend Uptrend Call (PACB)
Comtex SmarTrend(R) - Thu Feb 06, 4:48PM CST
SmarTrend identified an Uptrend for Pacific Biosciences of California (NASDAQACB) on December 16th, 2013 at $5.06. In approximately 2 months, Pacific Biosciences of California has returned 25.10% as of today's recent price of $6.33.

Why Pacific Biosciences of California Shares Cratered
Alex Planes, The Motley Fool - Motley Fool - Wed Feb 05, 3:28PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Pacific Biosciences of California have...

Pacific Biosciences of California, Inc. Announces Fourth Quarter 2013 Financial Results
GlobeNewswire - Tue Feb 04, 9:49PM CST
Pacific Biosciences of California, Inc. (NasdaqACB) today announced financial results for the fourth quarter ended December 31, 2013.

Pacific Biosciences of California Shares Up 44.7% Since SmarTrend's Buy Recommendation (PACB)
Comtex SmarTrend(R) - Thu Jan 30, 10:59AM CST
SmarTrend identified an Uptrend for Pacific Biosciences of California (NASDAQACB) on December 16th, 2013 at $5.06. In approximately 2 month, Pacific Biosciences of California has returned 44.66% as of today's recent price of $7.32.

Why Inteliquent, Pacific Biosciences of California, and Galectin Therapeutics Are Today's 3 Best Sto
Sean Williams, The Motley Fool - Motley Fool - Tue Jan 21, 4:15PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. With the Martin Luther King Jr. holiday shortening the trading...

Pacific Biosciences of California (PACB) Surges: Stock Moves 14.4% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Jan 21, 8:21AM CST
Pacific Biosciences of California, Inc. (PACB) was a big mover last session, as the company saw its shares rise by over 14% on the day.

Pacific Biosciences Of California (PACB) Stock Research Links

PACB Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Albertsons Welcomes Once Upon a Coconut Nationwide

Updated Category News Views 3

Coconut Water Takes Over Grocery Aisles You know, for all the cautious optimism I wield, this here is a move that shows real muscle in the world of coconut water—I mean, slamming into Albertsons' grocery empire is no small potatoes! Once Upon a Coconut has landed its premium hydration cans across all the banners under this giant retailer. From that good ol' familiar...

Continue Reading
Cannabis Industry Pushes for Robust Financial Services

Updated Category News Views 3

Industry Gears Up for Financial Action Clearly, cannabis businesses are shouting louder than a vendor at a ballgame, demanding more than just the basic chips-and-soda banking service. They’re on the hunt for serious credit facilities, payments, and the traditional financial tools that most sectors take for granted. I mean, check this out: Shield Compliance just dropped...

Continue Reading
Midlife ADHD in Women: New Challenges and Solutions

Updated Category News Views 6

ADHD Evolution in Women's Midlife They say change is the only constant, and boy, does that ring true for women navigating the turbulent seas of ADHD as they hit 40 and beyond. According to Germaine Swanson, the ADHD landscape changes dramatically in midlife, especially for women. We're talking about a mix of hormonal shifts, increasing life demands, and changes in brain...

Continue Reading
Atli Launches: AI-Powered eSIM Revolutionizes Travel

Updated Category News Views 2

What's New in Travel Tech: Atli's Debut Wandering the globe might sound romantic until you realize your phone's a paperweight without the right data. Enter Atli, a shiny new AI-powered travel eSIM service, snugged right into your WhatsApp. This marvel comes from the folks at XForge Mobile and aims to obliterate the hassle of getting connected abroad. You know those...

Continue Reading
Deadline Looms for EquipmentShare Investors' Legal Action

Updated Category News Views 2

Pressure Builds for EquipmentShare Investors If you've thrown some cash into EquipmentShare.com Inc. (NASDAQ: EQPT), it's time to sit up and pay attention. There's smoke on the horizon, and Faruqi & Faruqi, LLP is waving the flag. They've got a securities class action spinning fast, and if you've suffered any losses, September 21, 2026, is a date you don't want to forget....

Continue Reading
Red-Eye Flights Surge, Driven By Western U.S. Routes

Updated Category News Views 3

You can always count on some things staying the same, right? Well, if you thought red-eye flights were going to fade away, think again. These late-night wonders are not just hanging around—they're booming in the west like there's no tomorrow. Literally. Champion Traveler has laid it all out for us: about 115,580 overnight flights in 2025, a record high since this mad...

Continue Reading
Rare Collectibles Highlight Morphy's Auction on Oct 4

Updated Category News Views 2

Anticipation Builds for Morphy's Auction Event Morphy's upcoming event on October 4th is all about tapping into the era of revved engines, gleaming gasoline signs, and some history that could put Hollywood tales to shame. The auction isn't just a stroll down memory lane; it features over 650 lots, each a time capsule of America's automotive past. From Al Capone's ritzy...

Continue Reading
Cap Juluca: Caribbean Luxury Redefined on Maundays Bay

Updated Category News Views 7

The Tranquil Call of Maundays Bay Find me dipping my toes in the sands of Maundays Bay come October 10, 2026, and you'll understand why this slice of Anguilla stakes its claim to being the best beach on the globe. Cap Juluca, that crown jewel of Caribbean luxury, swings open its doors once more, promising indulgence framed by turquoise waters and the soft whisper of white...

Continue Reading
AbbVie's Bold Leap in Menstrual Migraine Treatment

Updated Category News Views 7

AbbVie's Game-Changing Atogepant Study When it comes to pushing boundaries in the pharmaceutical world, there's no sitting on the fence. AbbVie's Phase 3 LUNA study results are painting a bright picture for women who suffer from the relentless grip of menstrual migraines. In a world where not a single treatment option has been approved specifically for this condition,...

Continue Reading
Shareholder Rights in Focus: Examining Key Buyouts

Updated Category News Views 5

Shareholder Concerns Rise Amid Corporate Buyouts The stakes are high for the shareholders of Distribution Solutions Group, Eagle Financial Services, Safety Insurance Group, and Utz Brands as their companies face potential buyouts. Let's chew over what's on the table: the sweet deals insiders might score and the legal maneuvers in play. Halper Sadeh LLC, a heavy-hitting...

Continue Reading

Top 5 Most Recently Viewed Articles

PIMCO Canada Details Mergers for Enhanced Investment Funds

Updated Category News Views 103

Understanding the Proposed Mergers by PIMCO Canada PIMCO Canada Corp. recently announced exciting plans regarding the mergers of several closed-end funds. The proposed mergers, which involve the PIMCO Tactical Income Fund, PIMCO Tactical Income Opportunities Fund, and PIMCO Multi-Sector Income Fund, aim to create a new consolidated fund called the PIMCO Monthly Enhanced...

Continue Reading
Sodium Reduction Market: $11.5B by 2036, Wild Ride Ahead

Updated Category News Views 4

Riding the Sodium Reduction Wave Alright, folks, let's chew the fat about this sodium reduction ingredient market. It’s looking like it's gonna swell from $6.3 billion in 2026 to a whopping $11.5 billion by 2036. That's a steady 6.2% annual clip. We've got health-conscious consumers and government regulations kicking the demand for sodium reduction solutions into high...

Continue Reading
Evercore ISI Upgrades Microsoft Stock with Strong Fundamentals

Updated Category News Views 45

Evercore ISI Maintains Positive Outlook on Microsoft Stock Recently, Evercore ISI expressed confidence in Microsoft Corporation (NASDAQ: MSFT) by retaining its Outperform rating and an ambitious price target of $500.00. The firm stands by the company’s robust fundamentals, even amidst a slight slowdown in stock performance compared to the S&P 500 index. Understanding...

Continue Reading
Hess CEO Predicts Stronger Oil Market and Guyana Growth

Updated Category News Views 176

Hess CEO Shares Positive Outlook for Oil Demand John Hess, the CEO of Hess Corporation (NYSE: HES), recently expressed an optimistic perspective on the oil market during his presentation at a leading energy conference. He believes that the market is moving towards a balance rather than facing oversupply, despite concerns regarding demand from certain regions and...

Continue Reading
CorMedix Inc. Reports Strong Q3 Growth Fueled by DefenCath

Updated Category News Views 130

CorMedix Inc. Shows Promising Financial Growth in Q3 In a recent financial results conference call, CorMedix Inc. (NYSE American: CRMD) unveiled a significant achievement in the third quarter of 2024, with net revenue soaring to $11.5 million. This growth was primarily fueled by the successful launch and ongoing rollout of its flagship product, DefenCath. The company has...

Continue Reading